Gene · 2192
NIH grants1,030
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,030
Download this page as JSON| Grant | Title | FBLN1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL077612 | Precision phenotyping of emphysema in the elderly: the MESA Lung Study | 1 | 2025 |
| R01HL085440 | Resolution of inflammation in healing myocardial infarcts | 1 | 2025 |
| R01HL095524 | Modulation of Lung Disease by Genetic/Epigenetic Profiling | 1 | 2025 |
| R01HL117913 | The NOTCH Signaling Pathway in Large Vessel Vasculitis | 1 | 2025 |
| R01HL130020 | Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs | 1 | 2025 |
| R01HL132523 | Early Origins of Chronic Lung Disease: From Birth to Age 45 Years | 1 | 2025 |
| R01HL141278 | Alternative Protein Isoforms in Ventricular Remodeling | 1 | 2025 |
| R01HL142068 | T Cell Immunity in Giant Cell Arteritis | 1 | 2025 |
| R01HL148239 | Multimodal genetic regulatory architecture of coronary artery disease | 1 | 2025 |
| R01HL156860 | Epigenetic Regulation of the Maturation and Function of Lung Epithelium by the SWI/SNF Proteins ARID1A and ARID1B. | 1 | 2025 |
| R01HL157354 | Immunosuppression after cardiac arrest and resuscitation | 1 | 2025 |
| R01HL158668 | Molecular Determinants of Usual Interstitial Pneumonia (UIP) | 1 | 2025 |
| R01HL162299 | Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH | 1 | 2025 |
| R01HL163011 | Implications of PARP1 in myelodysplastic syndromes and targeted therapy | 1 | 2025 |
| R01HL164014 | Negative regulators of endothelial regeneration in aging lungs and ARDS | 1 | 2025 |
| R01HL164327 | Pharmacologic Contributors to Patent Ductus Arteriosus | 1 | 2025 |
| R01HL164409 | High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux | 1 | 2025 |
| R01MH123184 | Methods for single-cell CRISPR screens and multiomic data: constructing powerful well-calibrated tests, circumventing unmeasured confounding, and accounting for denoising and imputation | 1 | 2025 |
| R01NS057819 | MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROME | 1 | 2025 |
| R01NS099590 | The Unfolded Protein Response in Ischemic Stroke | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2192/grants?page=8